Medable

Webinar Date/Time: Tue, Sep 24, 2024 1:00 PM EDT

Webinar Date/Time: Wednesday, August 30, 2023 at 11am EDT

Wed, Aug 17, 2022 2:00 PM EDT Recent advances in both oncology drug development and novel digital technologies provide a ripe opportunity to enhance the clinical trial process. Join Colin Weller and Musaddiq Khan from Medable as they discuss the key considerations around these innovations.

There’s no doubt clinical research has changed. With 77% of surveyed pharma executives planning to run a hybrid or decentralized trial this year, it’s important to understand the benefits of web-enabled research tools and how they work. Learn the benefits of DCTs with this eBook.

Medable eConsent improves the trial experience for patients, sites, & sponsors. Learn how eConsent in conjunction with other decentralized solutions helped save one organization save $20M in trial costs, reduce trial site visits by 75%, and cut enrollment timelines in half with this case study.

The data is conclusive, DCTs provide better returns on investment than traditional trials. In fact, new analysis by Tufts CSDD shows DCTs can provide up to 13x ROI in phase III trials & 5x ROI in phase II trials through reductions in clinical trial cycle time, screen failure decreases, and more. Learn more with your free copy of the analysis.

A recent study by Morning Consult finds that >54% of US adults would be willing to participate in a clinical trial if it had a 30-minute-or-less commute. This is quite striking, given that